Stocks / ZTS

ZTS stock forecast

ZOETIS INC · Healthcare · Drug Manufacturers - Specialty & Generic

The model's rating

Greatly Outperform

ZTS is rated Greatly Outperform as of November 18, 2026: its medium-term return forecast is in the top fifth of the stocks the model scores.

Changed from Outperform on November 9, 2026.

Premium adds the numeric score behind this label, the medium-term return forecast, and today's full Upfront Picks.

Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.

ZTS is not among the 20 largest holdings published for 2026 Q4. See the portfolio

ZTS against the S&P 500

PeriodZTSS&P 500 (SPY)
1 month+8.2%-4.7%
3 months+12.3%-4.8%
Year to date-30.5%+7.9%
1 year-25.9%+11.8%

Total return, dividends included.

Key numbers

Price$85.57
Market cap34.77 Billion
P/E (trailing 12 months)14.5
P/S (trailing 12 months)3.7
P/B (latest quarter)10.1
Gross margin71.4%
Net profit margin26.1%
Return on equity76.4%
Beta0.6

As of November 5, 2026.

ZTS and its closest peers

StockCompanyMarket capModel rating
MTD METTLER TOLEDO INTERNATIONAL INC 34.55 Billion Greatly Underperform ZTS vs MTD
RMD RESMED INC 34.12 Billion Outperform ZTS vs RMD
CNC CENTENE CORP 33.39 Billion Greatly Outperform ZTS vs CNC
BIIB BIOGEN INC 37.16 Billion Greatly Outperform
ILMN ILLUMINA INC 31.75 Billion Outperform
GEHC GE HEALTHCARE TECHNOLOGIES INC 37.83 Billion Outperform GEHC vs ZTS

Questions

What does the Upfront Investment model say about ZTS?

The model rates ZOETIS INC (ZTS) "Greatly Outperform" as of November 18, 2026, which means its medium-term return forecast is in the top fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.

How is the ZTS rating produced?

A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.

Is ZTS in the Upfront Investment model portfolio?

ZTS is not among the 20 largest holdings published for 2026 Q4.

The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.